Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial session on understanding the Current Cancer Scenario in India. The landscape of cancer care in India is rapidly evolving, with a growing emphasis on personalized medicine. The integration of genomic testing has become increasingly important, moving beyond a one-size-fits-all approach to diagnosis and treatment. Recent advancements in technology and a better understanding of cancer biology are enabling healthcare providers to identify specific genetic mutations that drive tumor growth, leading to more targeted and effective therapies.
In a country as diverse as India, with a unique genetic makeup across its population, the importance of genomic testing is paramount. It allows for the identification of hereditary cancer syndromes, a more accurate prognosis, and the selection of therapies that are most likely to work for an individual patient. This is particularly relevant as India grapples with a rising cancer burden, where traditional treatments may not always be the most effective. Genomic testing, therefore, provides a roadmap for clinicians to navigate the complexities of cancer, offering a new level of precision and hope for better patient outcomes.
Therefore, get a deep understanding of the current cancer scenario in India and the transformative role of genomic testing and advanced diagnostics. Listen to this insightful discussion by Dr. Poonam Patil, grab the shared knowledge on the latest advancements in diagnosis and treatment, and follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
2.
Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.
3.
AI catches one-third of interval breast cancers missed at screening
4.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
5.
Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says
1.
Lymphomatoid Papulosis: What You Need to Know
2.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
3.
The Rise of Immunotherapy: New Advances in Cancer Treatment
4.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
5.
Patient Management Following Organ-Preserving Cancer Interventions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation